Browsing: Clinical Breakthroughs

A Northwestern resident physician has argued for the creation of a new federal department to lead a national “decarceration” program.

Transgender and nonbinary youth experienced sustained improvements in depression and anxiety over two years after starting treatment with gender-affirming hormones, according to a recent study.

Targeting cellular post-transcription mechanisms in the CD73 ectoenzyme may promote anti-tumor immunity and slow cancer progression in triple-negative breast cancer, according to a recent Northwestern Medicine study.

High doses of vitamin D alleviated symptoms for patients with toxic erythema of chemotherapy significantly faster than current treatments, according to a recent study.

Patients with relapsed or refractory hairy cell leukemia who were treated with vemurafenib experienced excellent response and relapse-free survival, according to a recent clinical trial published in Blood.

Direct-to-consumer platforms for testosterone therapy don’t always provide care in concordance with professional guidelines, according to a recent Northwestern Medicine study.

Patient-reported outcomes in relapsed or refractory large B-cell lymphoma revealed that receiving CAR T-cell immunotherapy was associated with higher quality of life, according to a recent study.

A team of Northwestern investigators led by Peter Penzes, PhD, has developed a new therapy that could treat Phelan-McDermid syndrome, a subtype of autism spectrum disorder.

Non-white racial and ethnic groups are underrepresented in OB-GYN clinical trials, according to a new Northwestern Medicine study.

Investigators have developed a novel personalized T-cell therapy approach that may identify specific targets unique to a patient’s cancer cells more effectively than current treatments, according to findings published in Nature.